Boxborough, MA, United States of America

Roger H Pak


 

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2007-2014

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Roger H Pak

Introduction

Roger H Pak is a prominent inventor based in Boxborough, MA (US), known for his significant contributions to the field of pharmaceuticals. With a total of 16 patents to his name, he has made remarkable advancements in the treatment of disorders associated with hyperproliferation, particularly cancer.

Latest Patents

Among his latest patents is the invention titled "Analogs of benzoquinone-containing ansamycins and methods of use thereof." This invention provides analogs of benzoquinone-containing ansamycins and their applications in treating and modulating disorders such as cancer. The invention focuses on reducing the benzoquinone to a hydroquinone and enhancing its solubility and stability through reaction with suitable acids. Another notable patent is "Ansamycin formulations and methods of use thereof," which includes solid forms of geldanamycin analogs and pharmaceutical compositions that inhibit Heat Shock Protein 90 (Hsp90). These innovations are crucial for developing effective cancer treatments.

Career Highlights

Roger H Pak has worked with notable companies in the pharmaceutical industry, including Infinity Pharmaceuticals, Inc. and Infinity Discovery, Inc. His work has been instrumental in advancing cancer therapies and improving patient outcomes.

Collaborations

Throughout his career, Roger has collaborated with esteemed colleagues such as Louis Grenier and James R Porter. These partnerships have fostered innovation and contributed to the success of his projects.

Conclusion

Roger H Pak's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight his role as a leading inventor. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…